ETF Digest
What are the core strengths of the UK genomics industry?
Posted
4 February 2022
Categories
Dr. Aphrodite N Spanou, Director for Healthcare, Life Sciences & Chemicals, at the UK’s Department for International Trade (DIT) mentions our portfolio company Eagle Genomics as one of the UK’s leading organisations in those sectors.
“Eagle Genomics is harnessing the power of the microbiome to transform knowledge of disease and wellness, while improving the health of the planet, including the onset and progression of debilitating chronic and metabolic diseases.” – Dr. Aphrodite N Spanou.
Read more on Health Tech World about the core strengths of the UK genomics industry and its global impact HERE.